ScholarIQanswers from OpenAlex & ORCID
Yutong Chen
ResearcherPublications, citations & collaboration network
Yutong Chen is a researcher indexed in ScholarIQ from OpenAlex & ORCID.
How many works does Yutong Chen have?
ScholarIQindexed works
Yutong Chen has 92 works in the ScholarIQ index. The count is the OpenAlex total, not the number of papers listed on this page.
How many citations does Yutong Chen have?
ScholarIQcitation count
Yutong Chen has 714 citations in the OpenAlex counts ScholarIQ stores.
What is the h-index of Yutong Chen?
ScholarIQh-index
Yutong Chen has an h-index of 15 in OpenAlex.
What is the i10-index of Yutong Chen?
ScholarIQi10-index
Yutong Chen has an i10-index of 21 in OpenAlex.
What is the ORCID of Yutong Chen?
ScholarIQorcid
The ORCID for Yutong Chen is on the source record.
What is the OpenAlex record for Yutong Chen?
ScholarIQopenalex
The OpenAlex for Yutong Chen is on the source record.
What are the most-cited papers on Yutong Chen?
ScholarIQmost cited works
AI-Based Reconstruction for Fast MRI—A Systematic Review and Meta-Analysis
Yutong Chen, Carola‐Bibiane Schönlieb, Píetro Lió, Tim Leiner, Pier Luigi Dragotti, Ge Wang, Daniel Rueckert, David Firmin, Guang Yang
The role of Platinum(IV)-based antitumor drugs and the anticancer immune response in medicinal inorganic chemistry. A systematic review from 2017 to 2022
Shihao Su, Yutong Chen, Pengfei Zhang, Ruijuan Ma, Wei Zhang, Jianing Liu, Tao Li, Hanjing Niu, Yi Cao, Bin Hu, Jin-Hua Gao, Hua Sun, Dong Fang, Jiajia Wang, Peng George Wang, Songqiang Xie, Chaojie Wang, Jing Ma
Disulfiram/Copper induces antitumor activity against gastric cancer via the ROS/MAPK and NPL4 pathways
Yao Liu, Xin Guan, Meiling Wang, Naixue Wang, Yutong Chen, Baolei Li, Zhuxuan Xu, Fu Fangwei, Cheng Du, Zhendong Zheng
TMX2 potentiates cell viability of hepatocellular carcinoma by promoting autophagy and mitophagy
Weiyu Zhang, Yao Tang, Pengfei Yang, Yutong Chen, Zhijie Xu, Chunhui Qi, Hongbin Huang, Ruiyang Liu, Haorui Qin, Haoying Ke, Caini Huang, Fuyuan Xu, Pengfei Pang, Zhiju Zhao, Hong Shan, Fei Xiao
Universal cutoff for tumor mutational burden in predicting the efficacy of anti-PD-(L)1 therapy for advanced cancers
Shu-Fen Mo, Zeng-Zhi Cai, Wen-Hao Kuai, Xuexin Li, Yutong Chen